Blinatumomab for Minimal Residual Disease Clearance in B-Acute Lymphoblastic Leukemia
Objective: To evaluate the efficacy, safety, and clinical impact of blinatumomab across the treatment continuum of B-cell acute lymphoblastic leukemia. Design…
Objective: To evaluate the efficacy, safety, and clinical impact of blinatumomab across the treatment continuum of B-cell acute lymphoblastic leukemia. Design…
Objective: To describe an exceptionally rare occurrence of chronic myeloid leukemia developing in the setting of relapsed refractory classical Hodgkin lymphoma…
Background: Capecitabine–oxaliplatin (CAPOX) is a commonly used chemotherapy regimen in gastric and colorectal malignancies. Although its efficacy has been well…
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting toxicity of neurotoxic chemotherapy that significantly impairs quality…
Background: Anemia is a frequent comorbidity in women with gynecological malignancies, adversely affecting tolerance to surgery, chemotherapy, and radiotherapy…
Objective: Cancer and chemotherapy are known risk factors for venous thromboembolism (VTE), and 75% of VTE-related deaths among cancer patients have been shown…